Bing-Yan Zhu

This inventor holds 79 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds (CPC class A61K). Top assignees: Millennium Pharmaceuticals Limited, Genentech, Inc., Cor Therapeutics, Inc.. Active years: 1998-2026.

USPTO Granted Patents = 79 (Patent Applications = 17)

% Patents Active = 68.4

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 4.9

ph-index = 17

Forward Citations = 1,245(Granted Patents)

Forward Citations (Not Self Cited) = 1,073(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Foster City, CA (US) (1998 - 2001)
Belmont, CA (US) (2000 - 2010)
South San Francisco, CA (US) (2011 - 2018)
Palo Alto, CA (US) (2006 - 2019)

Company Filing History:

30 out of 854

Millennium Pharmaceuticals Limited

Cor Therapeutics, Inc.

patents

4. 10 out of 181

F. Hoffmann-La Roche Ag

patents

5. 2 out of 5,024

Hoffmann-La Roche Inc.

Portola Pharmaceuticals, Inc.

patents

8. 1 out of 56

Constellation Pharmaceuticals, Inc.

patents

9. 1 out of 1

F. Hoffman-Laroche, Ag (Ex-US)

patent

10. 1 out of 1

Hoffman-Laroche, Inc. (US Only)

patent

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Factor Xa Inhibitors

PI3K Inhibitors

Pharmaceutical Compounds

Benzamides

Pyrazolo Compounds

Triazolopyridine

Thiazolopyrimidine

Benzopyran

JAK Inhibitors

Lactams

Therapeutic Compounds

Pentacyclic Kinase Inhibitors

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617802 - Sulfonimidamide compounds as NLRP3 modulators (2026-05-05),

2. 12275745 - Therapeutic compounds and methods of use (2025-04-14),

3. 12187709 - Lactams as CBL-B inhibitors selective over C-CBL (2025-01-07),

4. 12110276 - Pyrazolo compounds and methods of use thereof (2024-10-08),

5. 10179124 - Benzamides and related inhibitors of factor Xa (2019-01-15),

6. 9943519 - Pharmaceutical compounds (2018-04-17),

7. 9763922 - Therapeutic compounds and uses thereof (2017-09-19),

8. 9629831 - Benzamides and related inhibitors of factor XA (2017-04-25),

9. 9487533 - Phosphoinositide 3-kinase inhibitor compounds and methods of use (2016-11-08),

10. 9434732 - Triazolopyridine JAK inhibitor compounds and methods (2016-09-06),

11. 9309265 - Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use (2016-04-12),

12. 9108922 - Benzamides and related inhibitors of factor Xa (2015-08-18),

13. 8999998 - Pyrazolopyrimidine JAK inhibitor compounds and methods (2015-04-07),

14. 8993563 - Phosphoinositide 3-kinase inhibitor compounds and methods of use (2015-03-31),

15. 8987280 - Pyrazolopyrimidine PI3K inhibitor compounds and methods of use (2015-03-24),

Title: Bing-Yan Zhu: Pioneering Inventor from Palo Alto

Introduction: Bing-Yan Zhu is a distinguished inventor based in Palo Alto, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Bing-Yan Zhu holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Bing-Yan Zhu has worked with leading tech companies in Silicon Valley, where he has played a key role in developing innovative solutions that have revolutionized the industry.

Collaborations: Throughout his career, Bing-Yan Zhu has collaborated with top researchers, engineers, and scientists, both nationally and internationally, to push the boundaries of technological advancements and bring new ideas to life.

Conclusion: Bing-Yan Zhu's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the tech world, inspiring the next generation of innovators to push the limits of what is possible.